Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the old revision tag was removed and a minor UI element ('Back to Top') was eliminated.
    Difference
    0.6%
    Check dated 2025-09-13T17:35:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-09-06T14:56:13.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    39%
    Check dated 2025-08-30T11:41:45.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:36:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:49:34.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:19:58.000Z thumbnail image

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.